The average one-year price target for Exact Sciences (NasdaqCM:EXAS) has been revised to $100.65 / share. This is an increase of 19.01% from the prior estimate of $84.57 dated November 14, 2025. The ...
Investors in EXACT Sciences Corp. (Symbol: EXAS) saw new options become available today, for the December 18th expiration. One of the key inputs that goes into the price an option buyer is willing to ...
Exact Sciences (NASDAQ: EXAS) rallied nearly 20% on November 20 after Abbott Laboratories (NYSE: ABT) announced a $21 billion all-cash deal to acquire the molecular diagnostics company. The ...
Exact Sciences (NASDAQ:EXAS) has been analyzed by 16 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a concise overview ...
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The US equity ...
Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund holders during the fourth quarter of 2025. On February 20, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results